Related to PerkinElmer Assay Platform to Be Leveraged in Korea’s Sangmyung University’s GPCR Research

• MorphoSys Strikes GCPR Deal with Heptares
  
• Targeting Tau Protein Release Offers Hope for Alzheimer’s Patients
  
• A Good Day for Milestones
  
• Trevena to Use Ligand’s Library to Identify GPCR Therapeutics
  
• MSM Signs GPCR-Targeting Antibody Deals with Merck Serono and Debiopharm
  
• PerkinElmer Buys GE’s Catalog Radiochemicals, SPA Reagents, and Cytostar-T Plate Assets
  
• Trevena Awarded $7.65M NIH Grant to Search for Selective GPCR Ligands
  
• PerkinElmer and VWR Create Combined Service Solution
  
• BioLegend to Offer Services Based on PerkinElmer’s AlphaLISA Assay Technology
  
• BioFocus Gains Access to DiscoveRx GPCR and cAMP Assays
  
  
• Dimerix to Apply GPCR Heteromer Platform for Discovery of Drugs against Takeda Targets
  
• PerkinElmer Continues OneSource Service Contract with Minerva
  
• Ortho-McNeil-Janssen Taps Anchor for Pepducin Technology
  
• Cisbio to Distribute Multispan’s Portfolio of GPCR Cell Lines in the U.S.
  
• Omeros Gets $25M to Purchase Patobios’ GPCR Technology
  
• PerkinElmer and LinaTech to Offer Imaging Solutions for Cancer Treatment
  
• Cisbio Bioassays and Functional Genomics Institute Initiate Drug Discovery Program for CNS Diseases
  
• PerkinElmer to Take Over Distribution of NimbleGen CGX Cytogenetics Array Workflow from Roche
  
• Rutgers University Cell and DNA Repository Taps PerkinElmer NGS Sample Prep Solutions
  
• Macrogen Taps into PerkinElmer’s Sample Prep Solutions for Next-Gen Sequencing